June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
CLINICAL EFFICACY OF ULTRASONIC CIRCULAR CYCLO COAGULATION IN REFRACTORY GLAUCOMA. PRELIMINARY RESULTS
Author Affiliations & Notes
  • Paolo Fogagnolo
    Fondazione GB Bietti-IRCCS, Rome, Italy
  • Maurizio Digiuni
    University Eye Clinic, San Paolo Hospital, Milan, Italy
  • Emanuele Maggiolo
    University Eye Clinic, San Paolo Hospital, Milan, Italy
  • Luca Rossetti
    University Eye Clinic, San Paolo Hospital, Milan, Italy
  • Footnotes
    Commercial Relationships Paolo Fogagnolo, None; Maurizio Digiuni, None; Emanuele Maggiolo, None; Luca Rossetti, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3541. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Paolo Fogagnolo, Maurizio Digiuni, Emanuele Maggiolo, Luca Rossetti; CLINICAL EFFICACY OF ULTRASONIC CIRCULAR CYCLO COAGULATION IN REFRACTORY GLAUCOMA. PRELIMINARY RESULTS. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3541. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To report the preliminary data of clinical efficacy and safety of Ultrasonic Circular Cyclo Coagulation (UC3) in refractory glaucoma.

Methods: 11 patients were treated in our centre as a part of the multicenter Eye-Must study. 7 patients had previous trabeculectomies, 3 diode coagulation of ciliary body, 2 valve implant; 3 penetrating keratoplasty, 2 trauma, 2 retinal detachment. All patients were under maximum-tolerated topical treatment; 5 cases also received Diamox. Corneal edema was present in 4 patients. Treatment was performed in peribulbar anaesthesia in all cases; a partial coagulation of 6 fixed zones was obtained by means of a single-step procedure lasting about 2 minutes. Follow-up visits were performed at day 1, 7, 28. Data at month 3, 6, 9, 12 will be provided.

Results: Baseline IOP was 27.1±4.6 mm Hg. IOP at day 1, 7, and 28 was respectively 20.8±5.7, 18.6±6.1, 17.9±3.7 mm Hg; this corresponded to a mean reduction of 23%, 31%, 29%. At day 7, Diamox was discontinued in all patients except one (for this patient, it was reduced); no change in topical treatment was necessary in any patient. Treatment was well-tolerated in all cases. No major intra- or post-operative complications occurred. Mild conjunctival hyperemia was present at day 1 in all cases; 1 case had a mild corneal abrasion. At day 7, all side effects had resolved. At month 1, corneal edema disappeared in 3 patients, and reduced in 1. No patients required any other surgical procedure.

Conclusions: Based on our preliminary data, UC3 is a secure and effective treatment in refractory glaucoma.

Keywords: 455 ciliary body • 568 intraocular pressure  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×